Study guide
3.3 Antimicrobial Therapy, Antibiotic Prophylaxis & Antivirals/Antifungals
National Board Dental Hygiene Examination NBDHE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Head, Neck & Dental Anatomy, Histology & Embryology
1.1 Head & Neck Cranial Nerves, Osteology & Musculature 1.2 Tooth Morphology, Occlusion & Root Anatomy 1.3 Tooth Development, Histology & Embryology 1.4 Oral Physiology, Salivary Gland Function & TMJ Dynamics 1.5 General Pathology, Inflammation & Immunity Concepts
2 Chapter 2: Oral Pathology, Microbiology & Biofilm Ecology
2.1 Oral Mucosal Lesions, Soft Tissue & Salivary Pathology 2.2 Hard Tissue Anomalies, Cysts, Neoplasms & Radiographic Pathology 2.3 Periodontal Pathology, Plaque Biofilm Ecology & Microbiology 2.4 Cariology, Demineralization Mechanics & Fluoride Chemistry 2.5 Systemic Disease Manifestations & Oral Cancer Risk Factors 2.6 Genetic Conditions, Immunopathology & Diagnostic Biopsy Protocols
3 Chapter 3: Dental Pharmacology, Biochemistry & Nutrition
3.1 Autonomic Drugs, Cardiovascular & Respiratory Pharmacology 3.2 Analgesics, Opioids, NSAIDs & Central Nervous System Agents 3.3 Antimicrobial Therapy, Antibiotic Prophylaxis & Antivirals/Antifungals 3.4 Nutritional Biochemistry, Vitamins, Minerals & Dietary Analysis 3.5 Endocrine Pharmacology, Diabetic Care & Bone Metabolism Agents 3.6 Special Population Pharmacotherapeutics & Drug Interactions
4 Chapter 4: Patient Assessment, Risk Evaluation & Radiographic Interpretation
4.1 Health History Review, ASA Physical Status & Medical Risk Assessment 4.2 Comprehensive Extraoral/Intraoral Examination & Soft Tissue Inspection 4.3 Periodontal Assessment, Probing Techniques & Furcation Classification 4.4 Hard Tissue Examination, Caries Detection & Restorative Evaluation 4.5 Dental Radiography Principles, Physics, Technique & Radiation Safety 4.6 Radiographic Interpretation, Normal Landmarks & Pathologic Artifacts
5 Chapter 5: Periodontal Therapy, Instrumentation & Preventive Services
5.1 Periodontal Disease Etiology, Pathogenesis & Host Response 5.2 Non-Surgical Periodontal Therapy (NSPT) & Scaling/Root Planing (SRP) 5.3 Dental Hygiene Instrumentation, Ergonomics & Sharpness Maintenance 5.4 Preventive Oral Health Agents, Dentifrices, Rinses & Remineralization 5.5 Surgical Periodontal Therapy Overview & Maintenance Protocols 5.6 Patient Motivation, Behavioral Change & Oral Hygiene Instruction 5.7 Care Planning for Special Needs, Medically Compromised & Geriatric Patients
6 Chapter 6: Local Anesthesia Administration, Dental Materials & Special Care
6.1 Local Anesthesia Pharmacology, Neurophysiology & Vasoconstrictors 6.2 Injection Techniques, Anatomical Landmarks & Nerve Blocks 6.3 Local Anesthesia Complications, Toxicity & Nitrous Oxide Sedation 6.4 Dental Materials Chemistry, Impression Media & Restorative Auxiliaries 6.5 Pit & Fissure Sealants, Polishers & Biomaterial Biocompatibility 6.6 Orthodontic, Endodontic, Pediatric & Implant Patient Care
7 Chapter 7: Infection Prevention, OSHA/CDC Protocols & Medical Emergencies
7.1 Infection Control Principles, Transmission Pathways & Standard Precautions 7.2 Sterilization Methods, Biological Monitoring & Chemical Disinfection 7.3 OSHA Bloodborne Pathogens Standard, HazCom & Regulatory Compliance 7.4 Medical Emergency Recognition, CPR/AED & Protocol Management 7.5 Pharmacological Emergency Interventions & Airway Management 7.6 Instrument Processing Safety, Waste Management & Post-Exposure Protocols
8 Chapter 8: Community Oral Health, Epidemiology & Evidence-Based Research
8.1 Dental Public Health Principles, Community Assessment & Needs Analysis 8.2 Oral Epidemiology Indices: DMF, GI, PI, CPITN, Debris & Calculus Indices 8.3 Community Water Fluoridation Standards, Cost-Benefit & Public Health Policy 8.4 Evidence-Based Decision Making, Research Design, Control Groups & Sampling 8.5 Biostatistics in Dental Research: Mean, Median, P-values, Sensitivity & Specificity
9 Chapter 9: Integrated Case-Based Scenarios, Patient Cases & Professional Ethics
9.1 Case Scenario 1: Complex Periodontal Patient with Systemic Conditions 9.2 Case Scenario 2: Pediatric & Adolescent Preventive Management 9.3 Case Scenario 3: Medically Compromised & Special Needs Geriatric Patient 9.4 Case Scenario 4: Oral Pathology Identification & Interprofessional Referral 9.5 Professional Ethics, Jurisprudence & Dental Hygiene Practice Acts 9.6 Risk Management, Informed Consent & Interprofessional Collaboration
3.3 Antimicrobial Therapy, Antibiotic Prophylaxis & Antivirals/Antifungals
Key Takeaways Explain This Topic AI
Beta-lactam antibiotics (penicillins and cephalosporins) inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), exercising bactericidal activity against susceptible organisms.
Tetracyclines (e.g., doxycycline) bind to the 30S ribosomal subunit, exerting bacteriostatic action, and are contraindicated in pregnant women and children under 8 years due to intrinsic enamel discoloration and bone growth inhibition.
AHA guidelines require antibiotic prophylaxis for high-risk cardiac conditions (e.g., prosthetic heart valves, previous IE) prior to invasive dental procedures involving gingival manipulation or mucosal perforation.
Standard adult oral antibiotic prophylaxis for infective endocarditis is Amoxicillin 2 grams taken 30 to 60 minutes before the dental appointment.
Nystatin is a polyene antifungal that binds to ergosterol in fungal cell membranes, serving as a primary topical treatment for oral candidiasis (thrush, erythematous candidiasis, angular cheilitis).
Last updated: July 2026
3.3 Antimicrobial Therapy, Antibiotic Prophylaxis & Antivirals/Antifungals
Core Board Principle: Dental hygienists must possess complete mastery of antimicrobial mechanisms of action, adverse reaction profiles, and the current American Heart Association (AHA) guidelines for antibiotic prophylaxis to protect medically compromised patients from infective endocarditis while minimizing antimicrobial resistance.
Antimicrobial therapeutics are widely prescribed in dental practice for treating odontogenic infections, managing periodontal diseases, and preventing bacteremia-induced systemic complications. Distinguishing between bactericidal and bacteriostatic agents, identifying drug contraindications, and executing precise prophylaxis protocols are vital board competencies.
1. Antibacterial Mechanisms & Classification
Antibiotics are classified by their primary mechanism of action and whether they kill bacteria ( bactericidal ) or inhibit bacterial growth and replication ( bacteriostatic ). +---------------------------------------------------------------------------------------------+
- | MECHANISMS OF ANTIBACTERIAL AGENTS |
- +--------------------------------+--------------------+---------------+-----------------------+
- | TARGET / MECHANISM | DRUG CLASS | EFFECT | REPRESENTATIVE AGENTS |
- +--------------------------------+--------------------+---------------+-----------------------+
- | Cell Wall Synthesis Inhibition | Penicillins | Bactericidal | Amoxicillin, Pen VK |
- | (Binds PBPs, blocks crosslink) | Cephalosporins | Bactericidal | Cephalexin, Cefadroxil|
- | Protein Synthesis (50S subunit)| Macrolides | Bacteriostatic| Erythromycin, Azithro |
- | Protein Synthesis (50S subunit)| Lincosamides | Bacteriostatic| Clindamycin |
- | Protein Synthesis (30S subunit)| Tetracyclines | Bacteriostatic| Doxycycline, Minocycl |
- | Nucleic Acid / DNA Damage | Nitromidazoles | Bactericidal | Metronidazole |
- +--------------------------------+--------------------+---------------+-----------------------+
- Major Antibiotic Classes in Dentistry
Penicillins (Beta-Lactams): First-line therapy for odontogenic infections. Inhibits bacterial cell wall peptidoglycan synthesis via penicillin-binding proteins (PBPs). Amoxicillin is preferred over Penicillin V due to superior oral bioavailability and broader spectrum. Augmentin combines amoxicillin with clavulanic acid (a beta-lactamase inhibitor) to overcome bacterial resistance.
Macrolides (Azithromycin, Clarithromycin, Erythromycin): Bind reversibly to the 50S ribosomal subunit. Used as alternatives for penicillin-allergic patients. Erythromycin and clarithromycin are potent inhibitors of hepatic CYP3A4 enzymes, causing major drug interactions.
Tetracyclines (Doxycycline, Minocycline): Bind to the 30S ribosomal subunit. Possess anticollagenase properties (sub-antimicrobial dose doxycycline/Periostat inhibits matrix metalloproteinases in periodontitis).
CONTRAINDICATION: Tetracyclines chelate with divalent cations ( Ca 2 + \text{Ca}^{2+} Ca 2 + , Mg 2 + \text{Mg}^{2+} Mg 2 + , Fe 2 + \text{Fe}^{2+} Fe 2 + ). They are strictly contraindicated in pregnant women and children under 8 years of age because they bind to calcium in developing teeth, causing permanent intrinsic gray-brown staining and enamel hypoplasia.
Clindamycin: Binds to the 50S ribosomal subunit. Excellent penetration into bone and anaerobic soft tissue infections.
BLACK BOX WARNING: Clindamycin carries a high risk of causing Clostridioides difficile overgrowth, leading to severe, potentially fatal pseudomembranous colitis (manifested by severe watery diarrhea, abdominal cramps, and fever).
Metronidazole (Flagyl): Bactericidal agent that disrupts DNA structure in obligate anaerobic bacteria. Highly effective against aggressive periodontal pathogens ( Porphyromonas gingivalis , Treponema denticola ).
DISULFIRAM-LIKE REACTION: Metronidazole inhibits aldehyde dehydrogenase. Consuming alcohol while taking metronidazole induces severe disulfiram-like reactions (violent vomiting, flushing, tachycardia, throbbing headache).
2. AHA Guidelines for Antibiotic Prophylaxis
Invasive dental procedures can introduce oral bacteria into the bloodstream (transient bacteremia). In patients with specific underlying cardiac conditions, these bacteria can adhere to damaged heart tissue or prosthetic materials, causing Infective Endocarditis (IE) .
Cardiac Conditions Requiring Antibiotic Prophylaxis
According to the American Heart Association (AHA) and American Dental Association (ADA) guidelines, antibiotic prophylaxis prior to dental care is recommended ONLY for patients with the highest risk of adverse outcomes from IE:
Prosthetic Cardiac Valves or prosthetic material used for cardiac valve repair.
Previous History of Infective Endocarditis .
Congenital Heart Disease (CHD):
Unrepaired cyanotic CHD (including palliative shunts and conduits).
Completely repaired CHD with prosthetic material or device during the first 6 months after the procedure.
Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or device.
Cardiac Transplant Recipients who develop cardiac valvulopathy. +-------------------------------------------------------------------------------------+
- | PROCEDURES REQUIRING VS NOT REQUIRING PROPHYLAXIS |
- +--------------------------------------------------+----------------------------------+
- | PROPHYLAXIS REQUIRED | PROPHYLAXIS NOT REQUIRED |
- +--------------------------------------------------+----------------------------------+
- | All dental procedures that involve: | Routine anesthetic injections |
- | - Manipulation of gingival tissue | Taking dental radiographs |
- | - Manipulation of periapical region of teeth | Placement of removable prostheses|
- | - Perforation of the oral mucosa | Shedding of primary teeth |
- | (e.g., scaling, root planing, extractions) | Bleeding from trauma to lips |
- +--------------------------------------------------+----------------------------------+
- Recommended Prophylactic Regimens (Administered 30–60 minutes prior to procedure)
Standard Adult Oral Regimen: Amoxicillin 2.0 grams (Pediatric: 50 mg/kg).
Penicillin-Allergic Adult Oral Options:
Cephalexin 2.0 grams (or other 1st/2nd gen cephalosporin; avoid if patient has history of anaphylaxis or angioedema to penicillin).
Azithromycin or Clarithromycin 500 mg (Pediatric: 15 mg/kg).
Doxycycline 100 mg (Pediatric: <45 kg: 2.2 mg/kg; >45 kg: 100 mg).
- 3. Antifungal & Antiviral Therapeutics
- Antifungal Pharmacotherapy
Fungal cells contain ergosterol in their cell membranes (analogous to cholesterol in human cells). Antifungals target ergosterol synthesis or integrity.
Nystatin: A polyene antifungal that binds to ergosterol, creating membrane pores that cause cell leakage. Available as oral suspension (500,000 units rinse and swallow/spit 4 times daily) or troches for treating oral candidiasis (thrush, erythematous candidiasis, angular cheilitis).
Fluconazole (Diflucan): A systemic triazole antifungal that inhibits fungal cytochrome P450 ergosterol synthesis. Used for refractory or systemic candidiasis.
Clotrimazole (Mycelex): Synthetic azole available as 10 mg troches/lozenges dissolve in mouth.
Antiviral Therapeutics
Viral infections in dentistry primarily involve Herpes Simplex Virus Type 1 (HSV-1) and Human Immunodeficiency Virus (HIV) .
Acyclovir & Valacyclovir: Nucleoside analogs that inhibit viral DNA polymerase. Used topically or systemically for Primary Herpetic Gingivostomatitis and recurrent Herpes Labialis (fever blisters/cold sores). Treatment must begin during the prodromal stage (tingling/burning) for maximum efficacy.
Antiretroviral Therapy (ART) for HIV: Combines Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), and Protease Inhibitors. Successful ART reduces viral load to undetectable levels, preserving CD4 T-lymphocyte counts.
Loading diagram...